Clinical trial
Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures
NCT02954029 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hemostasis Pad Using Chitosan After Invasive Percutaneous Procedures
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- April 30, 2016
- Completion date
- December 31, 2017
- Enrollment
- 315 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, puncture